Jun 2026 (Q2 FY26) — Jul 31, 2026
Huntsman Q2 FY26 — Olin Merger Progress and Macro Headwinds
Read the full callHuntsman (HUN) earnings
- Mar 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Huntsman earnings: last reported Fri, 31 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,420 | +0.7% YoY | Quarterly, as filed | Quarter to Mar 2026 | Revenue from operations as filed. |
| Operating margin | -1.1 | −4.1 pts YoY | Operating profit / revenue | Quarter to Mar 2026 | For the quarter; a change is in percentage points. |
| Net profit | -53.0 | Quarterly, as filed | Quarter to Mar 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$8.33 −2.91% · −$0.25
Performance +1.3% 1Y
1Y: $8.22 on 17 Oct 2025 → $8.33. High $15.89 (15 Jun 2026), low $7.42 (6 Nov 2025).
- Previous close
- $8.58
- 52-week range
- $7.42 – $15.89
- One year
- +2.46%
Overview
- Symbol
- HUN
- Sector
- Materials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Huntsman earnings calls (HUN)
Financials
What the filings say
Net profit, year on year: −960% (quarter to mar 2026 against mar 2025).
| Line item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,574 | 1,540 | 1,452 | 1,410 | 1,458 | 1,460 | 1,355 | 1,420 |
| Operating profit | 34 | 42 | -63 | 42 | -120 | 6 | -59 | -16 |
| Operating margin | 2.2% | 2.7% | −4.3% | 3.0% | −8.2% | 0.4% | −4.3% | −1.1% |
| Profit before tax | 44 | 34 | -81 | 27 | -139 | -7 | -73 | -29 |
| Tax rate | 29.6% | 114.7% | −35.8% | 55.6% | −5.0% | −42.9% | −1.4% | −37.9% |
| Net profit | 22 | -33 | -141 | -5 | -158 | -25 | -96 | -53 |
| EPS ($ per share) | 0.13 | -0.19 | — | -0.03 | -0.92 | -0.14 | — | -0.31 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Reserves | 292 | 690 | 1,564 | 2,435 | 2,705 | 2,622 | 2,245 | 1,810 |
| Total liabilities | 5,204 | 5,496 | 5,040 | 4,833 | 4,380 | 3,770 | 3,951 | 4,058 |
| Fixed assets | 2,353 | 2,383 | 2,505 | 2,443 | 2,377 | 2,376 | 2,493 | 2,486 |
| Total assets | 7,953 | 8,320 | 8,713 | 9,392 | 8,220 | 7,248 | 7,114 | 7,015 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,207 | 897 | 253 | 952 | 914 | 209 | 263 | 289 |
| Cash from investing | -973 | -260 | 1,463 | -524 | -279 | 305 | -126 | -132 |
| Cash from financing | -424 | -450 | -655 | -977 | -994 | -620 | -326 | -76 |
| Net cash flow | -225 | 185 | 1,068 | -552 | -387 | -114 | -200 | 89 |
| Capital expenditure | -251 | -274 | -237 | -326 | -272 | -230 | -184 | -173 |
| Free cash flow | 956 | 623 | 16 | 626 | 642 | -21 | 79 | 116 |
Insider filings
49 filings between Nov 10, 2025 and Aug 3, 2026.
Open market
decisions to buy or sellPurchases
$1.22M
2 purchases by 2 insiders
Sales
None
No insider sold shares.
Compensation
not trading decisions- 13
- Award — granted as compensation
- 5
- Option exercise — converted options into shares
- 27
- Tax withheld — shares kept back by the company to cover tax
Also filed: 2 other filings.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Huntsman Peter R | $981.0K | — | Aug 3, 2026 |
| Lister Philip M. | $242.7K | — | Nov 10, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 3, 2026 | Huntsman Peter R Chairman, President & CEO | Purchase | 100,000 | $981.0K |
| Jul 31, 2026 | Buberl Jan Division President | Tax withheld | 422 | $4.1K |
| Jun 2, 2026 | Hansen Steen Weien Division President | Tax withheld | 883 | $13.2K |
| Feb 13, 2026 | Jorgensen Steven C. VP & Controller | Tax withheld | 414 | $5.5K |
| Feb 13, 2026 | Huntsman Peter R Chairman, President & CEO | Tax withheld | 21,662 | $286.2K |
| Feb 13, 2026 | Jorgensen Steven C. VP & Controller | Tax withheld | 321 | $4.2K |
| Feb 13, 2026 | Wright Scott J Division President | Tax withheld | 1,250 | $16.5K |
| Feb 13, 2026 | Rogers Robert Wade Sr. VP, Human Resources | Tax withheld | 2,329 | $30.8K |
| Feb 13, 2026 | Buberl Jan Division President | Tax withheld | 1,514 | $20.0K |
| Feb 13, 2026 | Wright Scott J Division President | Tax withheld | 2,096 | $27.7K |
| Feb 13, 2026 | Buberl Jan Division President | Tax withheld | 321 | $4.2K |
| Feb 13, 2026 | Jorgensen Steven C. VP & Controller | Tax withheld | 583 | $7.7K |
| Feb 13, 2026 | Buberl Jan Division President | Tax withheld | 414 | $5.5K |
| Feb 13, 2026 | Benko Brittany Sr. VP, EHS | Tax withheld | 630 | $8.3K |
| Feb 13, 2026 | Benko Brittany Sr. VP, EHS | Tax withheld | 1,281 | $16.9K |
| Feb 13, 2026 | Benko Brittany Sr. VP, EHS | Tax withheld | 909 | $12.0K |
| Feb 13, 2026 | Huntsman Peter R Chairman, President & CEO | Tax withheld | 16,804 | $222.0K |
| Feb 13, 2026 | Lister Philip M. Exec VP & CFO | Tax withheld | 1,579 | $20.9K |
| Feb 13, 2026 | Lister Philip M. Exec VP & CFO | Tax withheld | 2,375 | $31.4K |
| Feb 13, 2026 | Lister Philip M. Exec VP & CFO | Tax withheld | 3,706 | $49.0K |
| Feb 13, 2026 | Rogers Robert Wade Sr. VP, Human Resources | Tax withheld | 1,109 | $14.6K |
| Feb 13, 2026 | Huntsman Peter R Chairman, President & CEO | Tax withheld | 19,184 | $253.4K |
| Feb 13, 2026 | Rogers Robert Wade Sr. VP, Human Resources | Tax withheld | 1,417 | $18.7K |
| Feb 13, 2026 | Wright Scott J Division President | Tax withheld | 843 | $11.1K |
| Feb 13, 2026 | Hansen Steen Weien Division President | Option exercise | 1,513 | — |
| Feb 13, 2026 | Hansen Steen Weien Division President | Tax withheld | 449 | $5.9K |
| Feb 13, 2026 | Hansen Steen Weien Division President | Option exercise | 1,950 | — |
| Feb 13, 2026 | Hansen Steen Weien Division President | Tax withheld | 579 | $7.6K |
| Feb 13, 2026 | Hansen Steen Weien Division President | Option exercise | 3,141 | — |
| Feb 13, 2026 | Hansen Steen Weien Division President | Tax withheld | 932 | $12.3K |
| Feb 12, 2026 | Benko Brittany Sr. VP, EHS | Award | 26,375 | $0 |
| Feb 12, 2026 | Beckerle Mary C Director | Award | 12,434 | $0 |
| Feb 12, 2026 | Huntsman Peter R Chairman, President & CEO | Award | 372,268 | $0 |
| Feb 12, 2026 | Buberl Jan Division President | Award | 28,259 | $0 |
| Feb 12, 2026 | McGovern Jeanne Director | Award | 12,434 | $0 |
| Feb 12, 2026 | Hansen Steen Weien Division President | Award | 30,143 | $0 |
| Feb 12, 2026 | Smedley Amy Kay Exec VP, GC and Sec | Award | 56,518 | $0 |
| Feb 12, 2026 | Munoz Barcelo Jose Antonio Director | Award | 12,434 | $0 |
| Feb 12, 2026 | Rogers Robert Wade Sr. VP, Human Resources | Award | 37,679 | $0 |
| Feb 12, 2026 | Wright Scott J Division President | Award | 33,911 | $0 |
| Feb 12, 2026 | Jorgensen Steven C. VP & Controller | Award | 11,304 | $0 |
| Feb 12, 2026 | Lister Philip M. Exec VP & CFO | Award | 69,706 | $0 |
| Feb 12, 2026 | ESPELAND CURTIS E Director | Award | 12,434 | $0 |
| Feb 3, 2026 | Huntsman Peter R Chairman, President & CEO | Option exercise | 241,496 | $2.14M |
| Dec 2, 2025 | Wright Scott J Division President | Tax withheld | 24,088 | $251.7K |
| Dec 2, 2025 | Wright Scott J Division President | Option exercise | 27,211 | $241.1K |
| Nov 12, 2025 | Lister Philip M. Exec VP & CFO | Other | 49,704 | $0 |
| Nov 12, 2025 | Lister Philip M. Exec VP & CFO | Other | 49,704 | $0 |
| Nov 10, 2025 | Lister Philip M. Exec VP & CFO | Purchase | 29,762 | $242.7K |
| Aug 1, 2025 | Buberl Jan Division President | Tax withheld | 422 | $3.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Huntsman CORP
Free account. Everything above stays public.
Write why you follow Huntsman CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading